JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in ISI Web of Science Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Lirk, P. Articles by Klimaschewski, L. Search for Related Content PubMed Articles by Lirk, P. Articles by Klimaschewski, L. Related Collections Mechanisms Preclinical Pharmacology Pharmacology

---

ANESTHETIC PHARMACOLOGY

In Vitro, Lidocaine-Induced Axonal Injury Is Prevented by Peripheral Inhibition of the p38 Mitogen-Activated Protein Kinase, but Not by Inhibiting Caspase Activity

Philipp Lirk, MD, MSc^*, Ingrid Haller, MD^*, Hans Peter Colvin^*, Silke Frauscher, MD, Lukas Kirchmair, MD^*, Peter Gerner, MD, and Lars Klimaschewski, MD

From the *Department of Anesthesiology and Critical Care Medicine, and Division of Neuroanatomy, Innsbruck Medical University, Austria; and Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Address correspondence and reprint requests to Dr. Philipp Lirk, Department of Anesthesiology and Critical Care Medicine, Innsbruck Medical University, Anichstr. 35, 6020 Innsbruck, Austria. Address e-mail to philipp.lirk{at}i-med.ac.at.

BACKGROUND: All local anesthetics (LAs) are, to some extent, neurotoxic. Toxicity studies have been performed in dissociated neuron cultures, immersing both axon and soma in LA. This approach, however, does not accurately reflect the in vivo situation for peripheral nerve blockade, where LA is applied to the axon alone.

METHODS: We investigated lidocaine neurotoxicity in compartmental sensory neuron cultures, which are composed of one central compartment containing neuronal cell bodies and a peripheral compartment containing their axons, allowing for selective incubation. We applied lidocaine ± neuroprotective drugs to neuronal somata or axons, and assessed neuron survival and axonal outgrowth.

RESULTS: Lidocaine applied to the peripheral compartment led to a decreased number of axons (to 59% ± 9%), without affecting survival of cell bodies. During axonal incubation with lidocaine, the p38 mitogen-activated protein kinase inhibitor SB203580 (10 µM) attenuated axonal injury when applied to the axon (insignificant reduction of maximal axonal distance to 93% ± 9%), but not when applied to the cell body (deterioration of maximal axonal length to 48% ± 6%). Axonal co-incubation of lidocaine with the caspase inhibitor z-vad-fmk (20 µM) was not protective.

CONCLUSIONS: Whereas inhibition of either p38 mitogen-activated protein kinase or caspase activity promote neuronal survival after LA treatment of dissociated neuronal cultures, axonal degeneration induced by lidocain (40 mM) is prevented by p38 MAP kinase but not by caspase inhibition. We conclude that processes leading to LA-induced neurotoxicity in dissociated neuronal culture may be different from those observed after purely axonal application.

Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999